You just read:

BiondVax Receives €4M From the European Investment Bank (EIB) in Support of Ongoing Universal Influenza Vaccine Pivotal Phase 3 Trial

News provided by

Biondvax Pharmaceuticals Ltd

Oct 07, 2019, 09:15 ET